Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068834 · ClinicalTrials.gov registry record
Additional KIF6 Risk Offers Better Adherence to Statins
A clinical trial, sponsored by Medco Health Solutions.
- Completed
- Registry status
- 1,282
- Enrollment target
NCT01068834 is a clinical trial that has completed, run by Medco Health Solutions. The registered enrollment target is 1,282 participants.
The verdict
NCT01068834 has completed, sponsored by Medco Health Solutions.
- COMPLETED
- Registry status
- 1,282 participants
- Enrollment target
Study Summary
Many patients prescribed statins to lower their cholesterol stop taking their statin over time. The purpose of this study is to determine whether providing subjects their KIF6 carrier status (associated with increased cardiovascular event risk) will improve adherence to statin medications.
Interventions
- GENETIC KIF6 genetic test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,282 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068834
The ClinicalTrials.gov registry entry for NCT01068834 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medco Health Solutions, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KIF6 genetic test is the first listed.
NCT01068834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01068834 about?
NCT01068834 is a clinical study titled "Additional KIF6 Risk Offers Better Adherence to Statins". Many patients prescribed statins to lower their cholesterol stop taking their statin over time. The purpose of this study is to determine whether providing subjects their KIF6 carrier status (associated with increased cardiovascular event risk) will improve adherence to statin medications.
What is the current status of trial NCT01068834?
This trial is currently completed. The enrollment target is 1,282 participants. The study started on 2010-03. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01068834?
The interventions under investigation include: KIF6 genetic test (GENETIC).
Who is sponsoring clinical trial NCT01068834?
This trial is sponsored by Medco Health Solutions, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.